HIGHLIGHTS
- who: Mengmeng Dong from the of Turin, Italy have published the article: High serum IL-17A is associated with bone destruction in newly diagnosed multiple myeloma patients, in the Journal: (JOURNAL)
- what: The above articles all observed small clinical samples (four patients to dozens of patients), their conclusions about the relationship between TH17/IL-17 and MM prognosis are not uniform, and there was no article that studied bone disease, treatment efficacy, and PFS/overall survival (OS) in the same cohort. The 175 MM patients included in this study had an average age of 62 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.